Labcorp Holdings Inc. (LH) closed at $360.48 on October 29, 2026, rising 8.78% in the most recent 24-hour trading session. The move added to an already notable stretch of outperformance for the clinical laboratory and diagnostics company.
Over the past seven days, LH shares have gained 11.35%, and the stock has climbed 16.45% over the trailing 30-day period. The sustained upward trend has lifted the company's market capitalization to $26.86 billion.
The back-to-back sessions of broad gains reflect sustained buying pressure across the stock's recent trading history. No single catalyst was identified from the data provided, though the price action across all three measured timeframes points to consistent demand for shares.
Labcorp Holdings remains one of the larger publicly traded diagnostics companies by market value, and Thursday's session extended what has become one of its more notable short-term rallies in recent weeks.
